Article
Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jan 2006
Chen Taiping, Jackson Chad R, Link Andrew, Markey Michael P, Colligan Bruce M, Douglass Larry E, Pemberton Jackson O, Deddens James A, Graff Jeremy R, Carter Julia H
Abstract excerpt
PURPOSE: The transforming growth factor-beta (TGF-beta) signaling pathway has been frequently implicated in breast cancer. An intronic variant (Int7G24A) of TGF-beta receptor type I (TGFBR1) is associated with kidney and bladder cancers in our recent study. We hypothesize that this germline variant may be involved in development and progression of breast cancer. EXPERIMENTAL DESIGN: Case-control studies were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
